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Abstract
Based on internal ribosomal entry sites (IRES) of picornaviral origin we constructed a novel family of mammalian
expression vectors. pQuattro vectors contain quattrocistronic artificial eukaryotic operons which link, in a single
transcript, the simultaneous and coordinated as well as adjustable expression of up to three independent genes of
interest to a terminal neomycin (neo) resistance marker. Due to the strict genetic linkage of the transgenes and the
terminal selection marker, this genetic configuration enables, by the selection on neomycin, multigene metabolic
engineering of mammalian cells in a single step (one-step metabolic engineering). Furthermore, selection on the
terminal cistron of multicistronic expression units enforces cocistronic expression of all upstream encoded genes
and maximises genetic integrity of the eukaryotic operon in stable mammalian cell lines, since clones harbouring
damaged multicistronic expression units become neomycin-sensitive and are automatically counterselected (auto-
selection). The modular set-up and the abundance of restriction sites in pQuattro vectors facilitate the movement
of individual genes between multicistronic expression vectors and guarantees high compatibility with genetic
elements of a wide variety of existing mammalian expression vectors.
Introduction
Current metabolic engineering technology is in most
cases based on the transfection of a single transgene,
the expression of which is maintained and selected
for by cotransfection of a second vector encoding a
selectable marker which often confers resistance to
an antibiotic. However, due to unlinked expression of
the selection marker and the gene of interest, rarely
more than 30% of the stable integrants expressing the
antibiotic resistance also express the desired trans-
gene (Fussenegger et al., 1998a). This phenomenon
either results from a deletion or inactivation of the
gene of interest during or following plasmid integra-
tion or from the exclusive integration of the vector
encoding the resistance marker. Even if stable cell
lines with concomitant expression of the selection
marker and the gene of interest could be generated,
the expression level of the transgene is unpredictable
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and often decreases during extended cultivations since
there is no positive selection for the maintenance and
the transcriptional activity of the transgene.
Furthermore, as contemporary basic research con-
tinues to reveal more and more details on the molec-
ular complexity of metabolic pathways and networks,
classical one-gene metabolic engineering is becoming
increasingly limited in its potential to realised desired
global phenotypes. In order for metabolic engineer-
ing to keep up with the current detailed knowledge
of physiological pathways and metabolic networks
simultaneous expression of multiple genes is a pre-
requisite to achieve difficult-to-attain metabolic char-
acteristics or cell culture states (Papoutsakis, 1998;
Fussenegger et al., 1998b). Although current expres-
sion technology may in principle enable such multi-
gene metabolic engineering by subsequent rounds of
transfections with a single gene, such methodology is
tedious, time consuming, and increases the risk of gen-
erating secondary effects unrelated to the transgenes
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at every round of transfection due to random integra-
tions of the different vectors into the host chromosome
(Fussenegger et al., 1998a).
Results and discussion
Based on specific viral genetic elements which en-
able cap-independent translation initiation (internal
ribosomal entry sites, IRES; Fussenegger et al.,
this issue for a review), multicistronic expression
technology was recently established and success-
fully used for multigene metabolic engineering of
Chinese hamster ovary cells (CHO) (Papoutsakis,
1998; Fussenegger et al., 1998b; Fussenegger et
al., 1998c). The concept of multicistronic eukaryotic
expression leading to the quattrocistronic family of
mammalian expression vectors is based on the pre-
viously reported pTRIDENT system (Fussenegger et
al., 1998d). The tricistronic expression unit contained
in plasmid pTRIDENT1 consists of a tetracycline-
repressible promoter (PhCMV −1) and three multiple
cloning sites which are separated by two identical
IRES elements of polioviral origin (Fussenegger et
al., 1998d). In order to extend this tricistronic expres-
sion unit to the quattrocistronic level by the addition
of a selectable marker (pQuattro1), the SspI/BglII
fragment of pTRIDENT1 (PhCMV −1-MCSI-IRESI-
MCSII-IRESII-MCSIII) was fused to the correspond-
ing fragment of pIRESneo (SspI/BglII; Clontech, Palo
Alto, CA; Rees et al., 1996) containing a cap-
independent translation enhancer (CITE) an IRES el-
ement of the encephalomyocarditis virus (EMCV)
fused to the neomycin resistance gene as well as
the pUC-derived origin of replication (ori) for high
copy number amplification in E. coli (Figure 1; Ta-
ble 1). Additional quattrocistronic vectors pQuattro2,
pQuattro3 and pQuattro4 containing different regu-
latable as well as constitutive promoters such as the
ecdysone-responsive promoter (PEC ; pQuattro2), the
SV40 promoter (pQuattro3) and the MPSV promoter
(pQuattro4) were constructed by replacing PhCMV −1
of pQuattro1 by the respective promoter elements
(SspI/EcoRI) of pIND (Invitrogen), pSBC1 (Dirks
et al., 1993), and pMPSVEH (Dirks et al., 1994),
respectively (Figure 1).
In order to test the quattrocistronic expression unit,
pQuattro3 and pQuattro4 derivatives pMF143 and
pMF144 were constructed which harbour the secreted
alkaline phosphatase (seap, Berger et al., 1988), the
tumor suppressor gene p21 (El-Deiry et al., 1993), the
green fluorescent protein (GFP; Crameri et al., 1996)
and the neomycin resistance gene (Rees et al., 1996;
Table 1). In addition, a pQuattro1 derivative was con-
structed to assess tetracycline-dependent regulation of
the multicistronic expression unit (data not shown;
Fussenegger et al., 1998d). pMF143 and pMF144 re-
sulted from an EcoRI/BglII fusion of the pTRIDENT1
derivative pMF132 (Fussenegger et al., 1998d) and
the respective pQuattro vectors (Table 1). pMF143
and pMF144 were transfected into wildtype CHO-K1
cells (ATCC: CCL61) as described before (Fusseneg-
ger et al., 1997a). Transfected populations were grown
in FMX-8 medium (Messi Cell Culture Technology,
Switzerland) supplemented with 10% fetal calf serum
(FCS, Boehringer Mannheim, Lot Nr. 14713602) and
for the selection of stable transfectants also with
400 L mL−1 G418. The neomycin-resistant cell
population was qualitatively tested for expression of
SEAP, p21, and GFP using an enzymatic assay or (im-
muno)fluorescence microscopy (Berger et al., 1988;
Fussenegger et al., 1997a, Figure 2). Besides the
SEAP activity measured in the cell culture supernatant
the transfected cells show a coordinated expression
of p21 and GFP (Figure 2). Owing to the cytostatic
effect of the tumor suppressor gene p21, transfected
cells stop their cell cycle and cell division following
transfection of the quattrocistronic expression vector.
Consequently, cells harbouring the pQuattro deriva-
tives pMF143 and pMF144 are not able to proliferate
and remain single for extended time periods of at least
4 weeks and probably beyond that period (Figure 2).
Because of the instantaneous proliferation arrest of
CHO cells transfected with pMF143 and pMF144,
SEAP, p21 and GFP expression levels were assessed in
transient transfection experiments. The SEAP produc-
tion derived from pMF143 and pMF144 was identical
to levels expressed from pTRIDENT derivatives or
from isogenic mono- or dicistronic expression vec-
tors (Fussenegger et al., 1997a; Fussenegger et al.,
1998d). Similarly, (immuno)fluorescence intensities
of p21 and GFP were comparable to the ones de-
rived from isogenic di- or tricistronic configurations
(Fussenegger et al., 1997a; Fussenegger et al., 1998d).
Despite this complete proliferation block the cells
display no morphologies suggestive of apoptosis and
seem to remain viable since their cell membranes re-
tain intracellular GFP during the entire time period
(Figure 2; Fussenegger et al., 1997a). Certainly, p21
has been previously shown to arrest CHO cells at G1-
phase in transient transfection experiments at high in-
tracellular concentrations (Fussenegger et al., 1997a)
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Figure 1. Maps of pQuattro1-4. All mammalian expression vectors contain the high copy number pUC-derived ori as well as the ampicillin
resistance gene (bla) for high level amplification and selection in E. coli. The quattrocistronic expression units consist of three multiple cloning
sites, eukaryotic promoter elements PhCMV −1 (tetracycline-responsive), PEC (ecdysone-responsive) or the constitutive viral promoters
PSV 40and PMPSV , two internal ribosomal entry sites (IRES), a cap-independent translation enhancer (CITE) fused to the G418 resistance
gene (neo), and a terminal polyadenylation signal (pA) derived from bovine growth hormone.
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Figure 2. Immunofluorescence of CHO-K1 cells stably transfected with pMF143 (A and B) and pMF144 (C and D). A and C show immunoflu-
orescence of p21 encoded by the second cistron whereas B and D show GFP-mediated green fluorescence. The expression of both genes is
strictly correlated due to their expression from a single expression unit.
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Table 1. Plasmids used in this study
Plasmid Description Reference or source
pIND Cloning vector containing the ecdysone-regulatable promoter PEC Invitrogen
pIRESneo Dicistronic expression vector encoding neomycin resistance in the second cistron Clontech/Rees et al., 1996
pMPSVEH Cloning vector containing the strong, constitutive viral promoter PMPSV Dirks et al., 1994
pSBC1 Cloning vector containing the strong, constitutive viral promoter PSV 40 Dirks et al., 1993
pTRIDENT1 Tricistronic mammalian expression vector Fussenegger et al., 1997b
pMF132 pTRIDENT1-derivative harboring seap-p21-gfp in a tricistronic expression unit Fussenegger et al., 1997b
pMF143 pQuattro3 containing the tricistronic seap-p21-gfp-containing expression unit This work
of pMF132 (EcoRI/BglII)
pMF144 pQuattro4 containing the trisictronic seap-p21-gfp-containing expression unit This work
of pMF132 (EcoRI/BglII)
pQuattro1 BglII/SspI fusion of pTRIDENT1 and pIRESneo This work
pQuattro2 pQuattro1 containing the Ecdysone-responsive promoter of pIND (EcoRI/SspI) This work
pQuattro3 pQuattro1 containing the SV40 promoter of pSBC1 (EcoRI/SspI) This work
pQuattro4 pQuattro1 containing the MPSV promoter of pMPSVEH (EcoRI/SspI) This work
but stable transfection of regulated, PhCMV −1-based
p21-expression vectors such as recently developed for
the cytostatic production process were not able to
arrest the cell cycle, most probably due to insuffi-
cient expression levels (Fussenegger et al., 1997a;
Fussenegger et al., 1998c).
The pQuattro family of mammalian expression
vectors is a highly modular multicistronic expression
system which allows the simultaneous, coordinated
and, in some cases, adjustable expression of up to
three genes of interest which are transcriptionally
linked to the neomycin resistance marker in the ter-
minal cistron. The concept of the quattrocistronic
expression vectors presented here has several advan-
tages over existing mammalian expression systems
and has been designed for maximum compatibility
with existing and future expression technologies:
(1) pQuattro vectors contain three multiple cloning
sites harbouring up to 19 unique restriction sites
(pQuattro2), 7 of which represent 8 bp target se-
quences for restriction endonucleases. The abundance
of unique restriction sites present combined with the
modular configuration of the functional genetic ele-
ments (promoter cassettes, IRES and CITE elements)
avoids conflicting cloning situations arising from con-
secutive gene integrations, guarantees optimal com-
patibility with existing di- and tricistronic mammalian
expression vectors (Dirks et al., 1993; Dirks et al.,
1994; Rees et al., 1996; Fussenegger et al., 1998d)
and allows the downsizing of pQuattro to tri- and di-
cistronic vectors by deleting individual IRES elements
using either restriction sites contained in the MCS
(PmeI, BclI/BglII; SrfI/SwaI; BssHII/MluI) or in the
IRES elements (EspI). The vector backbone as well
as the neomycin resistance cassette are most easily
replaced using a restriction site of the various MCS
and the SspI (or XmnI) sites contained in the promoter
region of the ampicillin resistance gene (bla). Also,
the pQuattro vectors are compatible to the pIRESpuro
(Clontech) vector for SspI/BglII replacement of the
neomycin cassette with the puromycin resistance gene
and to the dual selection marker vectors pNeoEGFP
and pHygEGFP (Clontech) via SspI/MluI sites. Fur-
thermore, the promoter cassette of pQuattro vectors
can be replaced by corresponding SspI/EcoRI pro-
moter elements contained in a great variety of ex-
isting mammalian expression vectors (Dirks et al.,
1993 and 1994; Fussenegger et al., 1998). The mod-
ular structure of the pQuattro vector family allows
straightforward adaptation for special applications and
future expression technologies. Additionally, useful
promoter-IRESI-IRESII, IRESI-IRESII, IRESI-IRESII-
neo cartridges can be generated from the pQuattro
vectors.
A single AatII site at the 50 end of the mul-
ticistronic expression unit which is present in all
pQuattro vectors and allows further modifications and
integration of additional genetic elements.
(2) The pQuattro family of multicistronic expres-
sion vectors allows the simultaneous and coordinated
expression of up to three genes of interest which is
most useful for (i) multigene engineering of com-
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plex metabolic pathways (e.g. cell cycle and apopto-
sis or glycosylation; Fussenegger et al., submitted),
(ii) evaluation of multiple gene functions (functional
genomics), (iii) tissue engineering as well as cell and
gene therapy, (iv) auto-regulated expression systems
(Fussenegger et al., 1997b), (v) production of multi-
protein complexes (e.g. antibodies), (vi) production
of viral packaging cell lines (expression of gag, env,
pol), (vii) multi-antigen/epitope (DNA) vaccination or
(viii) the combination of antigens with immunomod-
ulatory or -stimulatory components (adjuvants). Fur-
thermore, the use of developmentally regulated IRES
elements (Bernstein et al., 1997) in multicistronic
expression units could superimpose additional trans-
lational regulation on multigene metabolic engineer-
ing approaches which would be especially valuable
for technologies such as tissue engineering and gene
therapy.
(3) pQuattro allows novel polycistronic ‘one-step
auto-select’ expression technology. Since the se-
lection marker is encoded by the terminal cistron
and transcriptionally and translationally linked to the
multicistronic expression unit (one-step multigene
metabolic engineering), selection on neomycin en-
sures the presence of all 50 cistrons (‘auto-select’
engineering) and exerts a positive selection pres-
sure for the maintenance of all genes encoded on
the multicistronic expression unit in an intact and
transcriptional active chromosomal context. Further-
more, after selection in G418-containing cell culture
medium, nearly all surviving colonies will stably ex-
press the gene of interest, thus decreasing the need
to screen large numbers of colonies to find func-
tional clones (Rees et al., 1996). Consequently, the
expression of proteins which impair cell viability or
genetic configurations imposing high counterselective
constraints (such as controlled proliferation engineer-
ing, Fussenegger et al., 1997a) are expected to be
selectable (Kaufman et al., 1991; Rees et al., 1996;
Müller et al., 1997). Auto-selection also decreases the
risk of genetic drift in bioprocesses (Rees et al., 1996).
Additionally, the CITE element contained in
pQuattro harbours a reduction-in-function mutation
which has been previously reported for the dicistronic
expression vector pIRESneo (Rees et al., 1996; Clon-
tech). The lower translation efficiency of the resistance
cistron has been repeatedly shown to be compensated
by the selection of chromosomal integration sites with
overall high transcription activity (Kaufman, et al.,
1991; Rees et al., 1996; Krömer et al., 1997).
Despite repetitive IRES elements, problems with
genetic stability of the pQuattro vectors has never
been observed neither during cloning or amplification
in E.coli nor following transfection into mammalian
cells (Fussenegger et al., 1997b and 1998). Taken
together, the family of quattrocistronic mammalian ex-
pression vectors harbours the potential for coordinated
multicistronic, auto-selective as well as regulatable ex-
pression of several transgenes in mammalian cells fol-
lowing a single engineering step. Owing to its modular
set-up, pQuattro can be easily adapted to any state-of-
the-art expression technology currently evaluated for
use in tissue engineering and gene therapy.
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